Naftifine

證據等級: L1 | 預測適應症: 8


## 藥師評估報告

Naftifine:從 皮膚黴菌病 到 皮膚念珠菌病

一句話總結

Naftifine(萘替芬)是一種烯丙胺類局部抗黴菌藥,用於治療皮膚黴菌感染。TxGNN 模型預測它對**皮膚念珠菌病 (cutaneous candidiasis)** 和**花斑癬 (pityriasis versicolor)** 有治療效果,這些預測與其已核准適應症高度一致,有充分文獻支持。

快速總覽

項目 內容
原適應症 皮膚黴菌病、表皮念珠菌病、甲黴菌病、花斑癬
預測新適應症 dermatophytosis of groin and perianal area、tinea pedis、tinea corporis、cutaneous candidiasis、Majocchi granuloma、ectothrix infectious disease、pityriasis versicolor、endothrix infectious disease
TxGNN 預測分數 99.84% (皮膚念珠菌病), 99.68% (花斑癬)
證據等級 L1
台灣上市 已上市
許可證數 多張
建議決策 Validate

預測適應症詳細分析

1. cutaneous candidiasis L4 99.84% 主要分析

為什麼這個預測合理?

Naftifine 通過抑制角鯊烯環氧化酶(squalene epoxidase),阻斷麥角固醇合成,破壞真菌細胞膜完整性。

</p>

此預測基於藥物的作用機轉,與現有臨床證據方向一致。

臨床試驗

目前無針對此特定適應症的臨床試驗登記。

相關文獻

PMID年份類型期刊主要發現
183464002008ArticleJournal of cutaneous medicine Naftifine: a review.
17233671991ArticleDrugsNaftifine. A review of its antimicrobial activity and therapeutic use in superfi...
30489141988ArticleCutisNaftifine cream in the treatment of cutaneous candidiasis.
241963402013ArticleJournal of drugs in dermatologOptimizing topical antifungal therapy for superficial cutaneous fungal infection...
188400062008ArticleDrugsTopical fenticonazole in dermatology and gynaecology: current role in therapy.
104399361999ArticleDrugsTerbinafine. An update of its use in superficial mycoses.
63881691984ArticleZeitschrift fur Hautkrankheite[Multicenter double-blind contralateral comparison of naftifin and clotrimazole ...
26209161989ArticleGiornale italiano di dermatolo[Evaluation of the efficacy of a new antimycotic molecule for topical use: nafti...
206775262010ArticleJournal of drugs in dermatologNaftifine, a topical allylamine.
</details>
2. Majocchi granuloma L4 99.69%

相關文獻(1 篇)

PMID年份類型期刊主要發現
232784842013ArticlePediatric dermatologyImpetigo-like tinea faciei around the nostrils caused by Arthroderma vanbreusegh...
3. ectothrix infectious disease L5 99.69%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
4. pityriasis versicolor L4 99.68%

相關文獻(8 篇)

PMID年份類型期刊主要發現
104399361999ArticleDrugsTerbinafine. An update of its use in superficial mycoses.
188400062008ArticleDrugsTopical fenticonazole in dermatology and gynaecology: current role in therapy.
221650422011ArticleSkinmedAn open-label study of naftifine hydrochloride 1% gel in the treatment of tinea ...
35318471986ArticleMykosenNaftifine solution (1%) in the treatment of pityriasis versicolor in Zambia.
241963402013ArticleJournal of drugs in dermatologOptimizing topical antifungal therapy for superficial cutaneous fungal infection...
119523032002ArticleJournal of the European AcademPityriasis versicolor resembling pityriasis rotunda.
26209161989ArticleGiornale italiano di dermatolo[Evaluation of the efficacy of a new antimycotic molecule for topical use: nafti...
83700531993ArticleCasopis lekaru ceskych[Naftifin--laboratory and clinical experience with a new antimycotic from the al...
5. endothrix infectious disease L3 99.65%

臨床試驗(1 項)

試驗編號階段狀態人數主要發現
NCT02658292PHASE2WITHDRAWN0A Double-Blind, Randomized, Vehicle-Control, Multicenter Study to Evaluate the E...
6. dermatophytosis of scalp or beard L4 99.65%

相關文獻(20 篇)

PMID年份類型期刊主要發現
349342942021ArticleInternational journal of trichBeard Reconstruction.
349840892021ArticleIndian journal of plastic surgBeard and Moustache Reconstruction.
375109082023ArticleJournal of clinical medicineBeard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation ...
381069582023ArticleInternational journal of psychStress, a Brief Update.
389369982024ArticleFacial plastic surgery clinicsFacial Hair in Hair Restoration Surgery: Beard Transplantation and Beard-To-Scal...
172325891903ArticleJournal of anatomy and physiolThe Germ-Cells.
394922012022ArticleFacial plastic surgery clinicsHair Restoration in the Ethnic Patient.
327165312020ArticleAORN journalClinical Issues-August 2020.
325417112020ArticleBritish dental journalBeards and masks.
324731652020ArticleDevelopmental biologyLong-lived zebrafish Rohon-Beard cells.
364876851874ArticleHall's journal of healthBeards.
372515892023ArticleEvolution lettersThe role of recognition error in the stability of green-beard genes.
406428542025ArticleAerospace medicine and human pBeard Length and the Efficacy of an Aviator Oxygen Mask.
349126722021ArticleWorld journal of plastic surgeHead and Neck Restoration in Scar Alopecia: Hair Transplantation in Scalp, Eyebr...
349840862021ArticleIndian journal of plastic surgUsing Nonscalp Hair in Scalp Hair Restoration-Theory and Execution.
360896972023ArticleThe Journal of craniofacial suHair-Bearing Expanded Scalp Flap for Total Beard Reconstruction in Patients With...
269424732016ArticleOrthopedicsTo Beard or Not to Beard? Bacterial Shedding Among Surgeons.
341465852021ArticleMathematical biosciencesQuantitative analysis of mitochondrial ATP synthesis.
385307382024ArticleIEEE transactions on pattern aMulti-Label Conditional Generation From Pre-Trained Models.
191162202008ArticleIntegrative cancer therapiesThe life and times of John Beard, DSc (1858-1924).
7. superficial mycosis L4 99.63%

相關文獻(20 篇)

PMID年份類型期刊主要發現
373558252023ArticleThe Journal of the AssociationNaftifine: A Topical Allylamine for Superficial Dermatophytosis.
183464002008ArticleJournal of cutaneous medicine Naftifine: a review.
17233671991ArticleDrugsNaftifine. A review of its antimicrobial activity and therapeutic use in superfi...
255028472015ArticleMycopathologiaGeneralized superficial mycosis caused by Trichophyton raubitschekii in China: c...
335177912021ArticleDrug deliveryDevelopment, optimization and characterization of nanoemulsion loaded with clove...
247190572014ArticleJournal of drugs in dermatologWhat is new in fungal pharmacotherapeutics?
241963402013ArticleJournal of drugs in dermatologOptimizing topical antifungal therapy for superficial cutaneous fungal infection...
268953662016ArticleJournal of the American PodiatAzole Resistance in Dermatophytes: Prevalence and Mechanism of Action.
250900202014ArticleThe Cochrane database of systeTopical antifungal treatments for tinea cruris and tinea corporis.
104399361999ArticleDrugsTerbinafine. An update of its use in superficial mycoses.
264618332015ArticleJournal of drugs in dermatologNew Topical Therapeutic Options in the Management of Superficial Fungal Infectio...
89962571997ArticleJournal of the American AcademChildhood white superficial onychomycosis caused by Trichophyton rubrum: report ...
188400062008ArticleDrugsTopical fenticonazole in dermatology and gynaecology: current role in therapy.
352448632022ArticleMycopathologiaA Special Tinea Nigra Caused by Curvularia lunata: Case Report and Literature Re...
261517842015ArticleJournal of drugs in dermatologAn Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Nafti...
81181611993ArticleArchives of medical researchNew topical antifungal drugs.
76190941994ArticleJournal of the American AcademAntifungal agents: an overview. Part II.
15509681992ArticleDermatology (Basel, SwitzerlanPreclinical data and mode of action of amorolfine.
221650422011ArticleSkinmedAn open-label study of naftifine hydrochloride 1% gel in the treatment of tinea ...
322327862020ArticleInfectionUnusual dermatomycoses caused by Nannizzia nana: the geophilic origin of human i...
8. tinea profunda L4 99.57%

相關文獻(1 篇)

PMID年份類型期刊主要發現
232784842013ArticlePediatric dermatologyImpetigo-like tinea faciei around the nostrils caused by Arthroderma vanbreusegh...
## 台灣上市資訊 | 許可證號 | 品名 | 劑型 | 核准適應症 | |---------|------|------|-----------| | 多張許可證 | 鹽酸萘替芬 | 乳膏/溶液 | 皮膚真菌病、表皮念珠菌病、甲黴菌病、花斑癬 | ## 安全性考量 **常見副作用:** - 局部灼熱感(6.8%) - 局部刺激 - 皮膚乾燥 - 紅斑 **禁忌症:** - 對 naftifine 或其他烯丙胺類藥物過敏 **使用注意:** - 僅供外用 - 避免接觸眼睛和黏膜 - 如出現明顯刺激應停藥 ## 結論與下一步 **決策:Validate** **理由:** TxGNN 預測的「皮膚念珠菌病」和「花斑癬」實際上已是 naftifine 在台灣的核准適應症(「表皮念珠菌病」和「花斑癬」)。文獻提供了充分的療效證據。此預測更多是對現有適應症的確認,而非新發現。 **若要推進需要:** - 此藥物已被核准用於預測適應症 - 無需額外驗證研究 - 可直接依據仿單使用 --- ## 相關藥物報告 - [Ipratropium](/drugs/ipratropium/) - 證據等級 L1 - [Temozolomide](/drugs/temozolomide/) - 證據等級 L1 - [Anastrozole](/drugs/anastrozole/) - 證據等級 L1 - [Icatibant](/drugs/icatibant/) - 證據等級 L1 - [Docetaxel](/drugs/docetaxel/) - 證據等級 L1 ---
用 AI 幫我深入分析

想進一步了解這個藥物的老藥新用潛力嗎?點擊下方按鈕,直接開啟 AI 助手進行分析。

Claude:點擊後會複製提問並開啟新視窗,請按 Ctrl+V(Mac: Cmd+V)貼上
ChatGPT:點擊後直接開啟並自動帶入提問

## 引用本報告 如需引用本報告,請使用以下格式: **APA 格式:** ``` TwTxGNN. (2026). Naftifine老藥新用驗證報告. https://twtxgnn.yao.care/drugs/naftifine/ ``` **BibTeX 格式:** ```bibtex @misc{twtxgnn_naftifine, title = {Naftifine老藥新用驗證報告}, author = {TwTxGNN Team}, year = {2026}, url = {https://twtxgnn.yao.care/drugs/naftifine/} } ``` ---
免責聲明
本報告僅供學術研究參考,不構成醫療建議。藥物使用請遵循醫師指示,切勿自行調整用藥。任何老藥新用決策需經過完整的臨床驗證與法規審查。

最後審核:2026-02-20 | 審核者:TwTxGNN Research Team

討論與回饋

歡迎分享您對本報告的看法、補充資訊或提出問題。討論內容會同步到 GitHub Discussions。 需要 GitHub 帳號才能留言。


回到頂部

Copyright © 2026 Yao.Care. 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.